|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.89 USD | +1.23% |
|
-16.71% | -9.97% |
Jan 5 (Reuters) - Allogene Therapeutics said on Friday it will cut 22% of its workforce as part of a clinical development strategy aimed at prioritizing its product pipeline.
The reduction in workforce is expected to be completed by the end of January 2024. (Reporting by Christy Santhosh; Editing by Krishna Chandra Eluri)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.97% | 493M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ALLOGENE THERAPEUTICS, INC. 
